Clinical trials: Atherosclerosis of Autologous Vein Coronary Artery Bypass Graft(s)

Atherosclerosis of Autologous Vein Coronary Artery Bypass Graft(s)

The eMESH 1 Feasibility Study

• Unknown status
• Age: 21 to 85 years
• Phase 1/2
• Medical device

Multi-center, dual cohort (randomized and single vessel) study designed to demonstrate feasibility, initial safety and performance of the Kips Bay Medical, Inc.

Trial name

eMESH 1 (NCT01676376)

Testing

eSVS Mesh treated saphenous vein graft, Control saphenous vein graft

Where

15 sites in United States, Czechia and 5 more

Volunteers

120 people

Sponsor

Kips Bay Medical, Inc.